Copyright © 1983 by the European Society of Cardiology.
© 1983, by the European Society of Cardiology
Coronary atherosclerosis and myocardial infarction in young women role of oral contraceptives
Divisions of Cardiology, Zentralkrankenhaus Links der Weser, Bremen, and Medical University Hannover, West Germany
Received 15 March 1982; revised 5 May 1982; .
Requests for reprints to: Prof. Dr. H.-J. Engel, Director, Division of Cardiology, Zentralkrankenhaus Links der Weser, D-2800 Bremen 61, West Germany
Abstract
According to their coronary anatomy and use of oral contraceptives, 76 patients aged
50 years with a history of acute myocardial infarction were allocated to one of four groups: groups I and II with contraceptive history without (g. I, n = 27) or with (gr. II, n = 15) coronary atherosclerosis, groups III and IV without oral contraceptive history with (gr. III, n = 27) or without (gr. IV, n = 7) coronary atherosclerosis. The patients were analysed with regard to their history, the incidence of atherogenic risk factors, and coronary and left ventricular angiograms.
Among 34 patients with myocardial infarction without coronary atherosclerosis (gr. I and IV), 27 had been using oral contraceptives at the time of myocardial infarction; with the exception of cigarette smoking, the incidence of atherogenic risk factors was low in this group. The analysis of atherogenic risk factors did not allow estimation of the susceptibility to cardiovascular side effects of oral contraceptives. Young women with typical coronary atherosclerosis (gr. II and III) had an unusually high incidence of atherogenic risk factors; oral contraceptives were used by 15 of 42 of these patients.
Among patients who had sustained a myocardial infarction during oral contraceptive medication, 64% did not have coronary atherosclerosis angiographically. Thus, myocardial infarctions under oral contraceptives may be a discrete disease entity unrelated to coronary atherosclerosis. Although oral contraceptives appear to increase the risk of myocardial infarction, they are not a typical atherogenic risk factor.
Key Words: Oral contraceptives myocardial infarction atherogenic risk factors thrombolysis coronary atherosclerosis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. R. ADAMS, M. S. ANTHONY, J. M. MANNING, D. L. GOLDEN, and J. S. PARKS Low-Dose Contraceptive Estrogen-Progestin and Coronary Artery Atherosclerosis of Monkeys Obstet. Gynecol., August 1, 2000; 96(2): 250 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Douglas and G. S. Ginsburg The Evaluation of Chest Pain in Women N. Engl. J. Med., May 16, 1996; 334(20): 1311 - 1315. [Full Text] [PDF] |
||||
![]() |
J. R. Kaplan, M. R. Adams, M. S. Anthony, T. M. Morgan, S. B. Manuck, and T. B. Clarkson Dominant Social Status and Contraceptive Hormone Treatment Inhibit Atherogenesis in Premenopausal Monkeys Arterioscler. Thromb. Vasc. Biol., December 1, 1995; 15(12): 2094 - 2100. [Abstract] [Full Text] |
||||


